Biotechs turn to gene silencing for obesity drugs that can last longer than Wegovy
By Allison DeAngelis and Elaine Chen May 23, 2024 for Stat News Enticed by the immense market opened by GLP-1 weight loss
Read MoreBy Allison DeAngelis and Elaine Chen May 23, 2024 for Stat News Enticed by the immense market opened by GLP-1 weight loss
Read MoreBy Rylee Wilson on May 21, 2024 for Becker’s Healthcare More hospitals are cutting ties with Medicare Advantage plans, and
Read MoreBy Suzanne Blake on May 22, 2024 for Newsweek Millennials are worried Medicare won’t be around for them when they
Read MoreBy Renuka Rayasam on May 21, 2024 for KFF Health News The makers of Ozempic and Mounjaro charge list prices
Read MoreBy Suzanne Blake on May 18, 2024 for Newsweek Medicare Advantage patients may be in for a rude awakening as
Read MoreBy Paul Anuzis on May 18, 2024 for Daily Independent When President Joe Biden took office, he embarked on a
Read More(By Brian Hurley and Paul N. Samuels for STAT) While many people immediately picture young adults when thinking about the
Read More(By Tammie Smith at The Kaiser Family Foundation published May 10, 2024) About one in eight adults (12%) say they
Read More(By Phil Galewitz for KFF Health News HOUSTON — Patients admitted to Houston Methodist Hospital get a monitoring device about
Read More(By Erica Carbajal for Becker’s Hospital Review) New research has found that nearly all people with two copies of the gene variant
Read More